Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Theravance Biopharma (TBPH) Change in Taxes: 2015-2020

Historic Change in Taxes for Theravance Biopharma (TBPH) over the last 6 years, with Dec 2020 value amounting to $258,000.

  • Theravance Biopharma's Change in Taxes was N/A to -$22.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$25.8 million, marking a year-over-year change of. This contributed to the annual value of $258,000 for FY2020, which is 93.03% down from last year.
  • Per Theravance Biopharma's latest filing, its Change in Taxes stood at $258,000 for FY2020, which was down 93.03% from $3.7 million recorded in FY2019.
  • In the past 5 years, Theravance Biopharma's Change in Taxes ranged from a high of $7.9 million in FY2017 and a low of -$9.5 million during FY2016.
  • Its 3-year average for Change in Taxes is -$1.4 million, with a median of $258,000 in 2020.
  • Per our database at Business Quant, Theravance Biopharma's Change in Taxes spiked by 182.86% in 2017 and then tumbled by 203.81% in 2018.
  • Over the past 5 years, Theravance Biopharma's Change in Taxes (Yearly) stood at -$9.5 million in 2016, then soared by 182.86% to $7.9 million in 2017, then tumbled by 203.81% to -$8.2 million in 2018, then surged by 145.17% to $3.7 million in 2019, then crashed by 93.03% to $258,000 in 2020.